Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02283307 · ClinicalTrials.gov registry record · NA
Dual Energy CT Urography With Reduced Iodinated Contrast
A NA study, sponsored by University of Washington.
- Completed
- Registry status
- NA
- Development phase
- 62
- Enrollment target
NCT02283307 is a NA study that has completed, run by University of Washington. The registered enrollment target is 62 participants.
The verdict
NCT02283307, a NA study, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- NA
- Development phase
- 62 participants
- Enrollment target
Study Summary
The goal of this study is to validate that Dual Energy CT (DECT) urography when performed with a 50% reduction in iodinated contrast dose results in a CT exam with equal or better image quality and equal or better diagnostic capability compared to traditional Single Energy CT (SECT) performed with a standard contrast dose.
Interventions
- OTHER Reduced contrast DECT scan
- OTHER Standard contrast SECT scan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 62 participants |
| Start Date | 2014-09 |
| Est. Completion | 2017-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02283307
The ClinicalTrials.gov registry entry for NCT02283307 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 62 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Reduced contrast DECT scan is the first listed.
NCT02283307 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02283307 about?
NCT02283307 is a clinical study titled "Dual Energy CT Urography With Reduced Iodinated Contrast". The goal of this study is to validate that Dual Energy CT (DECT) urography when performed with a 50% reduction in iodinated contrast dose results in a CT exam with equal or better image quality and equal or better diagnostic capability compared to traditional Single Energy CT (SECT) performed with a...
What is the current status of trial NCT02283307?
This trial is currently completed. It is a NA study. The enrollment target is 62 participants. The study started on 2014-09. Estimated completion is 2017-08.
What interventions are being tested in trial NCT02283307?
The interventions under investigation include: Reduced contrast DECT scan (OTHER), Standard contrast SECT scan (OTHER).
Who is sponsoring clinical trial NCT02283307?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.